Aug 25 |
We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate
|
Aug 19 |
New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT
|
Aug 9 |
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2024 Earnings Call Transcript
|
Aug 9 |
New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET
|
Aug 9 |
Acurx Pharmaceuticals GAAP EPS of -$0.26 misses by $0.04
|
Aug 9 |
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
|
Jul 17 |
USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome
|
Jul 16 |
Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update
|
Jul 15 |
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference
|
Jun 6 |
New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT
|